SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rubius Therapeutics, Inc. - RUBY
NEW YORK, April 11, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Rubius Therapeutics, Inc. . Such investors are advised to contact... | April 11, 2022
Source: marketscreener.com